Level Bio AB (publ) (NGM:LEVBIO)
0.2660
-0.0020 (-0.75%)
At close: Jul 18, 2025
Level Bio AB Revenue
Level Bio AB had revenue of 7.81M SEK in the quarter ending March 31, 2025, with 41.86% growth. This brings the company's revenue in the last twelve months to 27.40M, up 18.11% year-over-year. In the year 2024, Level Bio AB had annual revenue of 25.10M, down -3.83%.
Revenue (ttm)
27.40M
Revenue Growth
+18.11%
P/S Ratio
0.83
Revenue / Employee
2.74M
Employees
11
Market Cap
22.85M
Revenue Chart
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2024 | 25.10M | -999.39K | -3.83% |
Dec 31, 2023 | 26.10M | -8.24M | -23.99% |
Dec 31, 2022 | 34.33M | -9.63M | -21.91% |
Dec 31, 2021 | 43.96M | 20.43M | 86.86% |
Dec 31, 2020 | 23.53M | 6.45M | 37.77% |
Dec 31, 2019 | Pro | Pro | Pro |
Dec 31, 2018 | Pro | Pro | Pro |
Dec 31, 2017 | Pro | Pro | Pro |
Dec 31, 2016 | Pro | Pro | Pro |
Dec 31, 2015 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
Investor AB | 85.17B |
Atlas Copco AB | 173.03B |
AB Volvo | 500.08B |
EQT AB | 30.08B |
ASSA ABLOY AB | 152.95B |
Skandinaviska Enskilda Banken AB | 78.55B |
Sandvik AB | 121.46B |
Swedbank AB | 72.19B |